Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis

Laboratory Investigation

Volumn 90, Issue 11, 2010, Pages 1549-1557

  Anderson, H Clarke ^a   Mulhall, Douglas ^b,c   Garimella, Rama ^a,d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; exosomes; membrane vesicles; microparticles; microvesicles; osteoarthritis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; VASCULOTROPIN RECEPTOR;

ARTHRITIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHRONIC KIDNEY DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; EXOSOME; HOST CELL; HUMAN; JACOBSEN SYNDROME; KIDNEY DISEASE; MEMBRANE VESICLE; METASTASIS; NEOPLASM; NEPHROLITHIASIS; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT SURVEY; STOMACH ULCER; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 78049342425     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.152     Document Type: Short Survey

References (118)

1. Pap E, Pallinger E, Pasztoi M, et al. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009;58:1-8.
2. Anderson HC. Calcific diseases. A concept. Arch Pathol Lab Med 1983;107:341-348.
3. Tanimura A, McGregor DH, Anderson HC. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 1983;172: 173-177.
4. Hsu HH, Camacho NP. Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 1999;143:353-362.
5. Ganote CE, Philipsborn DS, Chen E, et al. Acute calcium nephrotoxicity. An electron microscopical and semiquantitative light microscopical study. Arch Pathol 1975;99:650-657.
6. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 1976;35:156-162.
7. Friedman I, Galey FR, Odnert S. The ultrastructure of tympanosclerosis. The source of the matrix vesicles and the pattern of calcospherules. Am J Otol 1981;3:144-149.
8. Ali SY, Griffiths S. Formation of calcium phosphate crystals in normal and osteoarthritic cartilage. Ann Rheum Dis 1983; 42(Suppl 1):45-48.
9. Matthews JL, Martin JH, Carson FL. Ultrastructure of calciphylaxis in skin. Metab Bone Dis Rel Res 1978;1:219-226.
10. Schoen FJ, Levy RJ, Nelson AC, et al. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-532.
11. Anderson HC. Electron microscopic studies of induced cartilage development and calcification. J Cell Biol 1967;35:81-101.
12. Lee WR, Laurie J, Townsend AL. Fine structure of a radiation-induced osteogenic sarcoma. Cancer 1975;36:1414-1425.
13. Schajowicz F, Cabrini RL, Simes RJ, et al. Ultrastructure of chondrosarcoma. Clin Orthop Relat Res 1974; 378-386.
14. Caulfield JB, Schrag PE. Electron microscopic study of renal calcification. Am J Pathol 1964;44:365-381.
15. Chen NX, O'Neill KD, Chen X, et al. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008;23:1798-1805.
16. Shanahan CM. Inflammation ushers in calcification: a cycle of damage and protection? Circulation 2007;116:2782-2785.
17. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-2867.
18. Bobryshev YV, Killingsworth MC, Lord RS, et al. Matrix vesicles in the fibrous cap of atherosclerotic plaque: Possible contribution to plaque rupture. J Cell Mol Med 2008;12:2073-2082.
19. Kim KM. Cell injury and calcification of rat aorta in vitro. Scan Electron Microsc 1984; (Part 4):1809-1818.
20. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006;98:905-912.
21. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009;75:890-897.
22. Demer LL, Tintut Y. Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 2003;23:1739-1743.
23. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006;26:1423-1430.
24. Kirsch T, Swoboda B, Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000;8:294-302.
25. Kirsch T. Annexins their role in cartilage mineralization. Front Biosci 2005;10:576-581.
26. Pasztoi M, Nagy G, Geher P, et al. Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts. Arthritis Res Ther 2009;11:R68.
27. Bakouboula B, Morel O, Faure A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177:536-543.
28. Chironi GN, Boulanger CM, Simon A, et al. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143-151.
29. Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-1275.
30. Dvorak HF, Quay SC, Orenstein NS, et al. Tumor shedding and coagulation. Science 1981;212:923-924.
31. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48:180-186.
32. Satta N, Freyssinet JM, Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol 1997;96:534-542.
33. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007;33:771-779.
34. Osterud B. The role of platelets in decrypting monocyte tissue factor. Dis Mon 2003;49:7-13.
35. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-1476.
36. Choi DS, Lee JM, Park GW, et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007;6:4646-4655.
37. Giusti I, D'Ascenzo S, Millimaggi D, et al. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 2008;10:481-488.
38. Dolo V, D'Ascenzo S, Violini S, et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 1999;17:131-140.
39. Valenti R, Huber V, Iero M, et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007;67:2912-2915.
40. Kim CW, Lee HM, Lee TH, et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 2002;62:6312-6317.
41. Mitchell PJ, Welton J, Staffurth J, et al. Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med 2009;7:4.
42. Andre F, Schartz NE, Chaput N, et al. Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 2002;20(Suppl 4):A28-A31.
43. Koga K, Matsumoto K, Akiyoshi T, et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 2005;25:3703-3707.
44. Andre F, Schartz NE, Movassagh M, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002;360:295-305.
45. Dolo V, Pizzurro P, Ginestra A, et al. Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies. J Submicrosc Cytol Pathol 1995;27:535-541.
46. Taraboletti G, D'Ascenzo S, Giusti I, et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 2006;8:96-103.
47. Ismail S, Hampton MB, Keenan JI. Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect Immun 2003;71:5670-5675.
48. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 2005;19:2645-2655.
49. Alaniz RC, Deatherage BL, Lara JC, et al. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 2007;179:7692-7701.
50. Bhatnagar S, Shinagawa K, Castellino FJ, et al. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007; 110:3234-3244.
51. Mashburn LM, Whiteley M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 2005;437:422-425.
52. Nowotny A, Behling UH, Hammond B, et al. Release of toxic microvesicles by Actinobacillus actinomycetemcomitans. Infect Immun 1982;37:151-154.
53. Grenier D, Mayrand D. Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect Immun 1987; 55:111-117.
54. Li Z, Clarke AJ, Beveridge TJ. Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria. J Bacteriol 1998;180:5478-5483.
55. Tanimura A, McGregor DH, Anderson HC. Calcification in atherosclerosis. I. Human studies. J Exp Pathol 1986;2:261-273.
56. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation 1996; 94:1175-1192.
57. Anderson HC, Reynolds JJ. Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. Dev Biol 1973; 34:211-227.
58. Towler DA. Oxidation, inflammation, and aortic valve calcification peroxide paves an osteogenic path. J Am Coll Cardiol 2008;52: 851-854.
59. Aikawa E, Nahrendorf M, Figueiredo JL, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007;116:2841-2850.
60. Warren BA, Vales O. The release of vesicles from platelets following adhesion to vessel walls in vitro. Br J Exp Pathol 1972; 53:206-215.
61. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19:43-51.
62. Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003;17:476-478.
63. Jy W, Jimenez JJ, Mauro LM, et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost 2005;3:1301-1308.
64. Leytin V, Allen DJ, Mutlu A, et al. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009;89:374-384.
65. Langer F, Holstein K, Eifrig B, et al. [Haemostatic aspects in clinical oncology]. Hamostaseologie 2008;28:472-480.
66. Jimenez JJ, Jy W, Mauro LM, et al. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001;112:81-90.
67. Galli M, Grassi A, Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost 1996;75:427-431.
68. Del Conde I, Bharwani LD, Dietzen DJ, et al. Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 2007;5:70-74.
69. Bonde HV, Talman ML, Kofoed H. The area of the tidemark in osteoarthritis-a three-dimensional stereological study in 21 patients. Apmis 2005;113:349-352.
70. Dequeker J, Mokassa L, Aerssens J, et al. Bone density and local growth factors in generalized osteoarthritis. Microsc Res Tech 1997;37:358-371.
71. Oettmeier R, Abendroth K, Oettmeier S. Analyses of the tidemark on human femoral heads. II. Tidemark changes in osteoarthrosis-a histological and histomorphometric study in non-decalcified preparations. Acta Morphol Hung 1989;37:169-180.
72. Thambyah A. A hypothesis matrix for studying biomechanical factors associated with the initiation and progression of posttraumatic osteoarthritis. Med Hypotheses 2005;64:1157-1161.
73. Cole AA, Kuettner KE. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop Scand Suppl 1995;266:98-102.
74. Chubinskaya S, Kuettner KE, Cole AA. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 1999;79: 1669-1677.
75. Distler JH, Jungel A, Huber LC, et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA 2005;102:2892-2897.
76. Blom AB, van Lent PL, Libregts S, et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metallo-proteinase 3. Arthritis Rheum 2007;56:147-157.
77. Valdes AM, Spector TD. The contribution of genes to osteoarthritis. Rheum Dis Clin North Am 2008;34:581-603.
78. Daniel L, Dou L, Berland Y, et al. Circulating microparticles in renal diseases. Nephrol Dial Transplant 2008;23:2129-2132.
79. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006;4:566-573.
80. Schoppet M, Shroff RC, Hofbauer LC, et al. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008;73:384-390.
81. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16: 3381-3388.
82. Berckmans RJ, Neiuwland R, Boing AN, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646.
83. Kim KM. Lipid matrix of dystrophic calcification and urinary stone. Scan Electron Microsc 1983; (Part 3):1275-1284.
84. Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 2004;8:75-88.
85. Nagasawa M, Koide H, Ohsawa K, et al. Purification of brush border membrane vesicles from rat renal cortex by size-exclusion chromatography. Anal Biochem 1992;201:301-305.
86. Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004;98:e55-e60.
87. Van Niel G, Porto-Carreiro I, Simoes S, et al. Exosomes: a common pathway for a specialized function. J Biochem 2006; 140:13-21.
88. Ginestra A, La Placa MD, Saladino F, et al. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 1998; 18:3433-3437.
89. Al-Nedawi K, Meehan B, Kerbel RS, et al. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009;106: 3794-3799.
90. Hegmans JP, Bard MP, Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004;164:1807-1815.
91. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005;113:752-760.
92. Hood JL, Pan H, Lanza GM, et al. Paracrine induction of endothelium by tumor exosomes. Lab Invest 2009;89:1317-1328.
93. Ploussard G, de la Taille A. Urine biomarkers in prostate cancer. Nat Rev Urol 2010;7:101-109.
94. Gesierich S, Paret C, Hildebrand D, et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 2005;11:2840-2852.
95. Zeelenberg IS, Ostrowski M, Krumeich S, et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res 2008;68: 1228-1235.
96. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581-593.
97. Xiu F, Cai Z, Yang Y, et al. Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes. J Mol Med 2007;85:511-521.
98. Ratajczak J, Wysoczynski M, Hayek F, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006;20:1487-1495.
99. Parent R, Mouton C, Lamonde L, et al. Human and animal serotypes of Bacteroides gingivalis defined by crossed immunoelectrophoresis. Infect Immun 1986;51:909-918.
100. Work E, Knox KW, Vesk M. The chemistry and electron microscopy of an extracellular lipopolysaccharide from Escherichia coli. Ann N Y Acad Sci 1966;133:438-449.
101. Bomberger JM, Maceachran DP, Coutermarsh BA, et al. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog 2009;5:e1000382.
102. Furuta N, Takeuchi H, Amano A. Entry of Porphyromonas gingivalis outer membrane vesicles into epithelial cells causes cellular functional impairment. Infect Immun 2009;77:4761-4770.
103. Pussinen PJ, Mattila K. Periodontal infections and atherosclerosis: mere associations? Curr Opin Lipidol 2004;15:583-588.
104. Kuramitsu HK, Kang IC, Qi M. Interactions of Porphyromonas gingivalis with host cells: implications for cardiovascular diseases. J Periodontol 2003;74:85-89.
105. Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 2003;35:259-267.
106. Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 2008;16:782-790.
107. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998;4:594-600.
108. Nokleby H, Aavitsland P, O'Hallahan J, et al. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. Vaccine 2007;25:3080-3084.
109. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26.
110. Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-1302.
111. Hornsey VS, McMillan L, Morrison A, et al. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion 2008;48:2508-2514.
112. Krailadsiri P, Seghatchian J, Williamson LM. Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations. Transfusion 2001;41:243-250.
113. Mayr M, Grainger D, Mayr U, et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet 2009;2:379-388.
114. Amabile N, Heiss C, Chang V, et al. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009;28:1081-1086.
115. Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010;6:21-29.
116. Gould SJ, Booth AM, Hildreth JE. The Trojan exosome hypothesis. Proc Natl Acad Sci USA 2003;100:10592-10597.
117. Prokopi M, Pula G, Mayr U, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009;114:723-732.
118. Sarkar K, Uhthoff HK. Ultrastructural localization of calcium in calcifying tendinitis. Arch Pathol Lab Med 1978;102:266-269.